| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |